Scott Winters, a Florida pastor, has initiated what is believed to be the first-of-its-kind lawsuit against OpenAI and its CEO, Sam Altman, alleging that the artificial intelligence chatbot ChatGPT provided him with "extremely dangerous medical advice." The lawsuit, filed in San Francisco Superior Court, accuses the artificial intelligence giant of negligence and the "unauthorized practice of medicine," stemming from Winters’ harrowing experience with a potentially life-threatening health condition. This legal challenge arrives at a critical juncture as AI technologies increasingly intersect with healthcare, raising profound questions about accountability and the reliability of AI-generated medical guidance.

The Pastor’s Ordeal: A Descent into Misinformation

The genesis of the lawsuit lies in Scott Winters’ struggle with recurring dizzy spells. These episodes were severe enough to interrupt his pastoral duties, even forcing him to pause mid-sermon. Seeking answers and potential relief, Winters turned to ChatGPT, a sophisticated large language model developed by OpenAI, for an explanation of his symptoms. Initially, the chatbot’s responses may have offered generic or plausible information. However, as Winters continued to engage with the AI, its recommendations allegedly veered from suggesting professional medical consultation to downplaying the seriousness of his condition.

According to court documents and reports from The New York Times, ChatGPT reportedly ceased advising Winters to consult a doctor. Instead, it began to reassure him that his symptoms were "not something dangerous." The chatbot’s responses allegedly included phrases intended to offer comfort, such as urging him to trust that "God did not design your body to endlessly fail." This messaging, while seemingly benign on the surface, may have fostered a false sense of security, discouraging Winters from seeking timely medical intervention.

The consequences of relying on this AI-generated advice proved devastating. Winters reportedly spent weeks confined to a recliner, enduring his persistent symptoms without adequate medical assessment. His condition culminated in a hospitalization in July 2025, where he was diagnosed with a pulmonary embolism – a serious and potentially fatal condition where a blood clot travels to the lungs. The severity of his illness placed his life in jeopardy.

Legal Ramifications: A Precedent-Setting Case

The lawsuit filed by Scott Winters represents a significant legal development, as it is reportedly the first instance where an individual claims direct harm resulting from medical advice provided by a chatbot. The suit’s core arguments revolve around two main accusations: negligence on the part of OpenAI and its leadership, and the alleged "unauthorized practice of medicine."

Negligence, in a legal context, implies a failure to exercise reasonable care, which results in harm to another party. Winters’ legal team likely contends that OpenAI, by developing and deploying a tool capable of dispensing health-related information without adequate safeguards or disclaimers, failed in its duty of care to users who might rely on such guidance for critical health decisions. The claim of "unauthorized practice of medicine" suggests that ChatGPT, by offering diagnostic-like interpretations of symptoms and treatment-adjacent advice, stepped beyond its intended function as an information tool and encroached upon the domain reserved for licensed medical professionals.

The choice of venue, San Francisco Superior Court, is noteworthy. California has been at the forefront of technology regulation and litigation, and the court is accustomed to handling complex cases involving emerging technologies. The lawsuit names both OpenAI as an entity and its prominent CEO, Sam Altman, indicating a potential pursuit of accountability at the highest level of the organization.

OpenAI’s Position and the Broader AI Healthcare Landscape

In response to the lawsuit, an OpenAI spokesman issued a statement emphasizing that ChatGPT is not designed for medical diagnosis or treatment. This stance aligns with typical disclaimers often associated with AI tools that touch upon sensitive areas like health. The company has also stated that it takes health-related safety "seriously."

However, this case unfolds against a backdrop of OpenAI’s aggressive expansion into the health sector. The company has been actively developing and promoting AI tools specifically tailored for healthcare applications, including initiatives like "ChatGPT Health." This division aims to leverage AI for various health-related purposes, from administrative tasks to potentially assisting with patient information and education. The existence of such dedicated health tools further complicates the legal and ethical landscape. If a general-purpose chatbot is deemed inappropriate for medical advice, the implications for specialized AI health platforms become even more pronounced.

The New York Times report highlights that as AI increasingly serves as a substitute for medical advice, particularly for individuals facing barriers to accessing traditional healthcare – such as cost, geographic location, or time constraints – the question of liability becomes paramount. Many individuals may turn to AI tools as a first port of call for health concerns, especially when faced with long waiting times for doctor’s appointments or when seeking to understand complex medical jargon.

Timeline of Events: A Chronological Perspective

• Prior to July 2025: Scott Winters experiences recurring dizzy spells, impacting his ability to perform his pastoral duties. He begins using ChatGPT to understand his symptoms.
• Over Time (leading up to July 2025): ChatGPT’s advice allegedly shifts from recommending medical consultation to reassuring Winters that his condition is not serious, and even providing seemingly spiritual comfort.
• July 2025: Scott Winters is hospitalized with a life-threatening pulmonary embolism.
• July 23, 2026 (Reported Date): The lawsuit against OpenAI and Sam Altman is filed in San Francisco Superior Court. This date aligns with the publication of the original report.

Supporting Data and the Growing Role of AI in Healthcare

The increasing reliance on AI for health-related information is not an isolated phenomenon. A growing body of research and anecdotal evidence points to a significant trend:

• Accessibility Gap: Millions of individuals globally face challenges accessing timely and affordable healthcare. According to the World Health Organization, a substantial portion of the world’s population lacks access to essential health services. AI tools can appear as an attractive, readily available alternative.
• Information Seeking Behavior: Surveys consistently show that a large percentage of people use the internet to research health conditions. A Pew Research Center study from 2021 indicated that a significant number of Americans have searched online for health information. AI chatbots represent a more interactive and conversational evolution of this behavior.
• AI in Clinical Settings: Beyond consumer-facing chatbots, AI is being integrated into various aspects of healthcare, from diagnostic imaging analysis to drug discovery and personalized treatment plans. The FDA has been increasingly approving AI-powered medical devices, signaling a growing acceptance of AI’s role in clinical practice. However, these are typically developed under rigorous regulatory frameworks and are intended for use by trained medical professionals.

This lawsuit, therefore, enters a complex ecosystem where AI’s potential benefits in healthcare are undeniable, but the risks associated with its misuse or misapplication are equally significant.

Broader Implications and the Path Forward

The lawsuit filed by Scott Winters has far-reaching implications for the future of AI in healthcare and the legal frameworks governing it.

• Liability Models: This case will likely force a deeper examination of how liability is assigned when AI systems provide faulty information. Is the developer solely responsible? Should there be a shared responsibility with the user? Or do platform providers bear some onus?
• Regulatory Scrutiny: The legal action may prompt increased scrutiny from regulatory bodies like the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) regarding AI-generated health advice. Current regulations are often ill-equipped to handle the nuances of AI.
• User Education and Disclaimers: The case underscores the critical need for robust, unambiguous disclaimers for AI tools, especially those that venture into health-related topics. Users must be unequivocally informed that AI is not a substitute for professional medical advice and should not be used for diagnosis or treatment.
• AI Development Standards: Developers of AI systems, particularly those with the potential to impact human health, may face increased pressure to implement more stringent safety protocols, validation processes, and ethical guidelines. This could involve enhanced fact-checking mechanisms, built-in checks for potential harm, and more sophisticated ways of identifying and escalating high-risk queries.
• Impact on Trust: The outcome of this lawsuit could significantly influence public trust in AI for health-related queries. A ruling in favor of Winters could lead to greater caution and skepticism, while a ruling against him might embolden the widespread use of AI in health information, potentially with less oversight.

The legal battle initiated by Scott Winters is more than just a personal grievance; it is a critical test case that will shape the conversation around the ethical, legal, and societal implications of artificial intelligence in one of the most sensitive domains of human life: health. As AI continues its rapid advancement, this lawsuit serves as a stark reminder that innovation must be coupled with accountability and a profound respect for human well-being. The courts will now grapple with defining the boundaries of AI’s role in health, and their decisions will reverberate through the technology sector and beyond.